Granules India Ltd clarifies on the presence of NDMA in company's Products

US FDA recently released its finding on the presence of NDMA beyond acceptable limits in certain products. With regard to this, Granules India Ltd is receiving requests from few of the investors for clarification on the status of presence of NDMA in its products.

The company has clarified that it has received communication from the US FDA stating that the US FDA has tested samples from a few lots of the company's API and Finished dosage tablets and the results "did not detect NDMA." There is some ongoing activity between the company and the US FDA and the company announces updates periodically to all the stakeholders and regulators.

Shares of GRANULES INDIA LTD. was last trading in BSE at Rs.173.85 as compared to the previous close of Rs. 167.6. The total number of shares traded during the day was 180218 in over 3737 trades.

The stock hit an intraday high of Rs. 179.1 and intraday low of 166.3. The net turnover during the day was Rs. 31468984.

Source : Equity Bulls

Keywords